Assessment of Peri-Procedural Myocardial Injury by High-Sensitivity Troponin-I Levels after Successful Elective Percutaneous Transluminal Coronary Angioplasty

Authors

  • Fahad Khan Toru Department of Adult Cardiology, Armed Forces Institute of Cardiology & National Institute of Heart Diseases/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Muhammad Shabbir Department of Adult Cardiology, Armed Forces Institute of Cardiology & National Institute of Heart Diseases/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Iftikhar Ahmed Department of Adult Cardiology, Armed Forces Institute of Cardiology & National Institute of Heart Diseases/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Aneela Shabbir Department of Biochemistry, Foundation University, Islamabad Pakistan
  • Sarwat Paiker Department of Adult Cardiology, Armed Forces Institute of Cardiology & National Institute of Heart Diseases/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Zeeshan Arif Department of Adult Cardiology, Armed Forces Institute of Cardiology & National Institute of Heart Diseases/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Zeeshan Ahmad Department of Adult Cardiology, Armed Forces Institute of Cardiology & National Institute of Heart Diseases/National University of Medical Sciences (NUMS), Rawalpindi Pakistan
  • Abdul Hameed Siddiqui Department of Adult Cardiology, Armed Forces Institute of Cardiology & National Institute of Heart Diseases/National University of Medical Sciences (NUMS), Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v74iSUPPL-1.10800

Keywords:

High-Sensitivity Troponin-I, Myocardial Injury, Percutaneous transluminal coronary angioplasty

Abstract

Objective: To determine the incidence of Peri-Procedural Myocardial Injury (PMI) after elective, successful Percutaneous Transluminal Coronary Angioplasty (PTCA) as assessed by High Sensitivity troponin-I (HS-Trop-I) levels, and to find out association between PMI and clinical, angiographic and procedural variables.

Study Design: Analytical Cross-sectional study.

Place and Duration of Study: Armed Forces Institute of Cardiology/National Institute of Heart Diseases, Rawalpindi Pakistan, from Dec 2022 to Jun 2023.

Methodology: Total one hundred and thirty-one cases were included using consecutive sampling technique. Patients with stable angina and having at least one positive stress test, baseline pre-PCI cardiac troponin level below the 99th percentile upper reference limit (normal baseline troponin), and a target lesion with a stenosis of >70% on qualitative angiography were included in study. Patients were divided into two groups; (Group-I=HS-Trop-I>40ng/L and Group-II=HS-Trop-I≤40 ng/L). Independent samples t-test and Pearson’s Chi-square test were applied to compare the study variables among study groups and p<0.05 was considered as statistically significant.

Results: PMI was reported in 60(45.8%) out of 131 patients. Hypertension and previous myocardial infarction demonstrated slightly higher prevalence in group-I but there was insignificant difference in frequencies of demographics and comorbid in study groups (p>0.05). Total stent length and max balloon time, were significantly higher in the group-I (50.73±25.19mm vs 31.13±17.83mm; 26.80±7.51sec vs 22.42±5.94sec respectively) (p<0.001). There was also statistically significant difference in frequency of AHA classification, number of diseased vessels and multi-vessel PCI in study groups (p<0.001).

Conclusion: PMI is a common complication of elective PCI, especially when patients present with high-risk......

Downloads

Download data is not yet available.

References

Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation 2022; 145(8): e153-e639.

https://doi.org/10.1161/CIR.0000000000001052

Kiramijyan S, Liu MWJRRCC. The benefits of drug-eluting stents in the treatment of coronary artery disease 2016; 7: 9-25.

https://doi.org/10.2147/RRCC.S54203

Zhang W, Jin F, Zhou H, Wang W. Evaluating the occurrence of increased postoperative cardiacenzymes in patients with coronary atherosclerotic obstruction. Cell Mol Biol (Noisy-le-grand) 2022; 68(1): 124-9.

https://doi.org/10.14715/cmb/2022.68.1.16

Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging 2005; 111(8): 1027-32.

https://doi.org/10.1161/01.CIR.0000156328.28485.AD

Soud M, Ho G, Hideo-Kajita A, Yacob O, Waksman R, McFadden EP, et al. Periprocedural myocardial injury: Pathophysiology, prognosis, and prevention 2020; 21(8): 1041-52.

https://doi.org/10.1016/j.carrev.2020.04.011

Wu Y, Pan N, An Y, Xu M, Tan L, Zhang L. et al. Diagnostic and Prognostic Biomarkers for Myocardial Infarction. Front Cardiovasc Med 2020; 7: 617277.

https://doi.org/10.3389/fcvm.2020.617277

Arboine-Aguirre LA, Galvan-Garcia JE, Palacios-Rodriguez JM, Guzman-Ramirez D. Valor pronostico de la troponina I posintervencionismo coronario percutaneo electivo. Gac Med Mex 2018; 154(3): 320-6.

https://doi.org/10.24875/GMM.18003359

Abbas S KN, Samore N, Khan Q, Majeed SM. Frequency Of Common Modifiable Risk Factors In Patients With Myocardial Damage Undergoing Single Vessel Coronary Angioplasty. PAFMJ 2014; 1: S35-8.

Zhang D, Xu B, Yin D, Li Y, He Y, You S, et al. Predictors and Periprocedural Myocardial Injury Rate of Small Side Branches Occlusion in Coronary Bifurcation Intervention. Medicine (Baltimore) 2015; 94(25): e992.

https://doi.org/10.1097/MD.0000000000000992

Lansky AJ, Stone GW. Periprocedural Myocardial Infarction. Circulation: Cardiovascular Interventions 2010 Dec; 3(6): 602–10.

https://doi.org/10.1161/CIRCINTERVENTIONS.110.959080

Zeitouni M, Silvain J, Guedeney P, Kerneis M, Yan Y, Overtchouk P, et al. Periprocedural myocardial infarction and injury in elective coronary stenting. European Heart Journal 2018 Jan 20; 39(13): 1100–9. https://doi.org/10.1093/eurheartj/ehx799

Nehal Badr Elnahhas, Khaled El-Menyawi, Mostafa AE, Mostafa El Nozahi. The Relationship between Elevated Pre-procedural Random Blood Glucose Level and Periprocedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention 2021 https://doi.org/10.21608/ejhm.2022.263573

Liu MJ, Chen CF, Gao XF, Liu XH, Xu YZ. Impact of periprocedural myocardial injury on long-term clinical outcomes of chronic total occlusion patients undergoing percutaneous coronary intervention. Coronary Artery Disease 2020 May; 31(3): 208–14. https://doi.org/10.1097/MCA.0000000000000813

Akin Izgi, Ali Cevat Tanalp, Kirma C, Cihan Dündar, Vecih Oduncu, Mustafa Akçakoyun, et al. Predictors and Prognostic Significance of Troponin-I Release following Elective Coronary Angioplasty 2006 Nov 1; 34(6): 612–23.

https://doi.org/10.1177/147323000603400606

Skorupski W, Kałużna-Oleksy M, Mitkowski P, Skorupski W, Grajek S, Małgorzata Pyda, et al. Peri-Procedural Troponin Elevation after Percutaneous Coronary Intervention for Left Main Coronary Artery Disease 2022; 12(1): 244–4.

https://doi.org/10.3390/jcm12010244

Zanchin T, Lorenz Räber, Koskinas KC, Piccolo R, Jüni P, Pilgrim T, et al. Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention 2016 Jun 1; 9

https://doi.org/10.1161/Circinterventions.115.003202

Herrmann J. Prognostic implication of cardiac troponin T increase following stent implantation. Heart 2002 Jun 1; 87(6): 549–53.

https://doi.org/10.1136/heart.87.6.549

Ueki Y, Otsuka T, Bär S, Koskinas KC, Heg D, Häner J, et al. Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI. Journal of the American College of Cardiology 2022 Feb 15; 79(6): 513–26.

https://doi.org/10.1097/HCO.0000000000000995

Downloads

Published

30-05-2024

Issue

Section

Original Articles

How to Cite

1.
Toru FK, Shabbir M, Ahmed I, Shabbir A, Paiker S, Arif Z, et al. Assessment of Peri-Procedural Myocardial Injury by High-Sensitivity Troponin-I Levels after Successful Elective Percutaneous Transluminal Coronary Angioplasty. Pak Armed Forces Med J [Internet]. 2024 May 30 [cited 2024 Jun. 16];74(SUPPL-1):S32-S37. Available from: https://pafmj.org/PAFMJ/article/view/10800